Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.52% Nasdaq Down1.11%

Anthera Pharmaceuticals, Inc. (ANTH)

-NasdaqGM

0.60 May 22, 3:59PM EDT

Add to Portfolio
Insider RosterGet Insider Roster for:
Insider Holders*
Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
HEALY JAMES
Director
Option Exercise
Jan 27, 2012
77,412
Jan 27, 2012
HENNEY CHRISTOPHER S
Director
Purchase
Jun 28, 2012
302,429
Jun 28, 2012
HISLOP COLIN
Officer
Acquisition (Non Open Market)
Mar 24, 2013
144,091
Mar 24, 2013
KILFOIL GEORGINA
Officer
Disposition (Non Open Market)
Jan 2, 2013
30,035
Jan 2, 2013
LOWE CHRISTOPHER P.
Officer
Acquisition (Non Open Market)
Mar 24, 2013
108,915
Mar 24, 2013
ODINK DEBRA
Officer
Acquisition (Non Open Market)
Mar 24, 2013
177,259
Mar 24, 2013
ORBIMED ADVISORS LLC
Director
Purchase
Jan 29, 2013
7,462,000

Jan 29, 2013
SOFINNOVA VENTURE PARTNERS VI L P
Beneficial Owner (10% or more)
Sale
Dec 29, 2011
44,969
Dec 29, 2011
THOMPSON DAVID E.
Director
Disposition (Non Open Market)
Nov 6, 2011
7,758

Nov 6, 2011
TRUEX PAUL F
Officer
Disposition (Non Open Market)
May 20, 2013
727,181
May 20, 2013
VANTAGEPOINT VENTURE ASSOCIATES IV LLC
Beneficial Owner (10% or more)
Option Exercise
Jul 6, 2011
5,357,528
Jul 6, 2011

View Transactions for Insiders & Institutional Holders

 
* Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.